Xpect Giardia/Cryptosporidium Kit, Ref 24050520, 20 tests per kit, For In Vitro Diagnostic Use. A rapid test for the direct qualitative detection of Giardia and Cryptosporidium antigens in fecal specimens.
FDA Recall Z-2432-2008 · Posted 2008-09-19
Advertisement
Recalling FirmRemel, Inc
Recall StatusTerminated
Product CodeMHI
Date Initiated2008-08-11
Date Terminated2010-01-21
Product Quantity3,974 kits
Reason for Recall
Faint grey test lines for Cryptosporidium may be visible which may be interpreted as false positive
Firm Action
The recalling firm issued letters dated 6/19/08 flagged "IMPORTANT PRODUCT INFORMATION" which advised their customers of the issue with the faint grey test lines but did not request any action be taken, such as return or destruction of the affected lot numbers. The recalling firm issued a second letter flagged "IMPORTANT MEDICAL DEVICE CUSTOMER ADVISORY NOTICE" dated 8/11/08 and was issued via regular mail on 8/14/08. This letter asked users to review their inventory for the product lots indicated in the letter, discard all remaining units of this product lot, complete and return the Product Inventory Checklist regardless if they have affected product. A "PRODUCT INVENTORY CHECKLIST" was enclosed to report whether the firm had product to discard and the amount to be replaced.
Root Cause
Process control
Distribution Pattern
Worldwide Distribution --- including USA and countries of Canada and U.K.
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement